Papers by Keyword: Calvarial Defect

Abstract: The purpose of this study was to evaluate histologically the effect of LiF-maleic acid added calcium aluminate (LM-CA) bone cement and calcium aluminate-polymethylmethacrylate (CA-PMMA) composite bone cement on bone regeneration in rat calvarial defect. After calvarial defects in 8 mm in diameter were created, three groups of 10 animals, a total of 30, each either received LM-CA bone cement, CA-PMMA composite bone cement or a sham-surgery control. Histologic analysis was done at 2 weeks and 8 weeks of healing periods. We concluded that LM-CA bone cement can be used as a bioactive bone graft material due to ability of bonding to the existing bone and CA-PMMA can be used as a graft material for augmentation of bone-volume due to dimensional stability.

Abstract: The purpose of this study was to compare the bone regenerative effect of calcium phosphate glass according to the particle size in vivo. We prepared two different sizes, that is 400 μm and 40 μm, of calcium phosphate glass powder using the system CaO-CaF2-P2O5-MgO-ZnO. Critical-sized calvarial defects were created in 60 male Sprague-Dawley rats. The animals were divided into 3 groups of 20 animals each. Each defect was filled with a constant weight of 0.5 g calcium phosphate glass powder mixed with saline. As controls, the defect was left empty. The rats were sacrificed 2 or 8 weeks after postsurgery, and the results were evaluated using histological as well as histomorphometrical studies. The particle size of the calcium phosphate was crucial; 400 μm particles promoted new bone formation, while 40 μm particles inhibited it because of severe inflammation.

Abstract: b-Ca3(PO4)2 (TCP) based cement combined with polyphosphate was investigated. In the bone cement composed of b-TCP, monocalcium monophosphate (MCPM) and calcium sulfate hemihydrate (CSH), effect of the amount of setting agent on workability, setting time, temperature rise and compressive strength was evaluated. The polyphosphate, which was selected as a growth enhancer, could be introduced without affecting the properties of cement. The polyphosphate containing cement was introduced at the calvarial defect in a rabbit. After three months, the defect was covered with newly formed bone, in contrast with the case of polyphosphate free bone cement. These results suggest that the bone cement containing inorganic polyphosphate can be used as effective bone filler with considerable potential of bone regeneration for bony defects.